Diabetes Technology & Therapeutics
Editor-in-Chief: Satish K. Garg, MD
Latest Impact Factor* is 2.698
*2016 Journal Citation Reports® (Clarivate Analytics, 2017)
The only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.View Aims & Scope…
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.